Investing.com - Gilead reported third quarter earnings that beat analyst's expectations on Thursday and revenue that topped forecasts.
The firm reported earnings per share of $1.84 on revenue of $5.6B. Analysts polled by Investing.com forecast EPS of $1.62 on revenue of $5.37B. That compared to EPS of $2.27 on revenue of $6.51B in the same period a year earlier. The company had reported EPS of $1.91 on revenue of $5.65B in the previous quarter.
Gilead shares gained 1.43% to trade at $69.60 in after-hours trade following the report.
For the year, Gilead shares are down 4.95%, under-performing the Nasdaq which is up 5.49% year to date.
Gilead follows other major Healthcare sector earnings this month
On October 16, J&J (NYSE:JNJ) reported third quarter EPS of $2.05 on revenue of $20.35B, compared to forecasts of EPS of $2.03 on revenue of $20.04B.
Novartis ADR earnings beat analyst's expectations on October 18, with third quarter EPS of $1.32 on revenue of $12.78B. Investing.com analysts expected EPS of $1.31 on revenue of $12.98B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar